Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Patent
1995-10-30
2000-06-20
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
A61K 3324
Patent
active
060775459
ABSTRACT:
An improved diluent for the preparation of cisplatin suspensions from a lyophilized powder is provided. The diluent contains a pharmaceutically acceptable nonionic surfactant, which improves the accuracy and homogeneity of the therapeutic formulation. The suspension may be used directly, or may be used in preparing gel formulations for direct injection into a neoplastic lesion or surrounding tissue.
REFERENCES:
patent: 4619913 (1986-10-01), Luck et al.
patent: 5019394 (1991-05-01), Hamaguchi et al.
patent: 5214174 (1993-05-01), Miyamoto et al.
Wagner et al., Fortschr. Atomspektrom. Spurenanal., Band 2, pp. 139-149, 1986.
Araki et al., "Newly Developed Transarterial Chemoembolization Material: CDDP-Lipiodol Suspension", Gastrointest Radiol (1989), 14:46-48.
Nagase et al., "Effects of Intralesional Versus Ip Administration of Cisplatin on Squamous Cell Carcinoma of Mice", Cancer Treatment Reports (1987), 71:825-829.
Theon et al., "Intratumoral Chemotherapy with Cisplatin in Oily Emulsion in Horses", JAVMA (1993), 202:261-267.
Landrito et al., "Effects of Intralesional Injection of Cisplatin Dissolved in Urografin and Lipiodol on Ehrlich Ascites Tumor and Normal Tissues of CD-1 Mice", Cancer Chemother Pharamacol. (1994), 34:323-330.
Sternlicht et al., "Renal Cisplatin Chemoembolization with Angiostat, Gelfoam, and Ethiodol in the Rabbit: Renal Platinum Distributions", Radiology (1989), 170:1073-1075.
Yodono et al., "Combination Chemoembolization Therapy for Hepatocellular Carcinoma: Mainly, Using Cisplatin (CDDP)", Cancer Chemother Pharmacol. (1989), 23:42-44.
Verrijk et al., "Reduction of Systemic Exposure and Toxicity of Cisplatin by Encapsulation in Poly-lactide-co-glycolide", Cancer Research (1992), 52:6653-6656.
Ichida et al., "Treatment of Hepatocellular Carcinoma with a CDDP-Epirubicin-Lipiodol Suspension: a Pilot Clinico-Pharmacological Study", Cancer Chemother Pharmacol (1992), 31:51-54.
Natsume et al., "Investigation on Utility of Viscous Ethyl Oleate Containing Cis-Diamminedichloroplatinum(II) in Tumor-Bearing Animals," Drug Delivery Syst., 6(3):213-219 (1991) Abstract Only.
Jones Richard E.
Maskiewicz Richard
Roskos Kathleen V.
Goldberg Jerome D.
Matrix Pharmaceuticals, Inc.
LandOfFree
Process and composition for therapeutic cisplatin (CDDP) does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Process and composition for therapeutic cisplatin (CDDP), we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process and composition for therapeutic cisplatin (CDDP) will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1850095